Proteomic analysis of a human prostate cancer cell line after incubation with a novel somatostatin14 derivative

Cancer Genomics and Proteomics

Volumn 2, Issue 6, 2005, Pages 347-352

  Liu, Zhaoxu ^a,b   Marquez, Marcela ^a   Nilsson, Sten ^a   Holmberg, Anders R ^a   Alaiya, Ayodele ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SHANDONG UNIVERSITY   (China)

Author keywords

LNCaP cell line; Proteomic analysis; Somatostatin

Indexed keywords

PROTEIN SMSDX; SOMATOSTATIN 14; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RANK SUM TEST; TWO DIMENSIONAL ELECTROPHORESIS;

EID: 30044433099     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Crawford ED, Rosenblum M, Ziada AM and Lange PH: Hormone refractory prostate cancer. Urology 54(suppl 6A): 1-7, 1999.
2. 111In]-labeled DTPA-O-[Phe-]-octreotide scintigraphy. Cancer Res 55(suppl 23): 5805-5810, 1995.
3. Vainas IG: Octreotide in the management of hormone-refractory prostate cancer. Chemotherapy 47(suppl 2): 109-126, 2001.
4. Moreau JP, Kim S, Dong JZ, Ignatious F, Jackson S, Moreau SC, Morgan BA, Touraud F, Taylor JE, Tissier B, Pellet M, Murphy W and Davis T: Improved analogs and novel delivery systems for somatostatin octapeptides. Metabolism 45(8 Suppl 1): 24-26, 1996.
5. Wulbrand U, Feldman M, Pfestroff A, Fehman HC, Du J, Hiltunen J, Marquez M, Arnold R, Westlin JE, Nilsson S and Holmberg AR: A novel somatostatin conjugate with a high affinity to all five somatostatin receptor subtypes. Cancer 15: 1293-1297, 2002.
6. Behe M, Du J, Becker W, Behr T, Angerstein C, Marquez M, Hiltunen J, Nilsson S and Holmberg AR: Biodistribution, blood half-life, and receptor binding of a somatostatin-dextran conjugate. Med Oncol 18: 59-64, 2001.
7. Pinski J, Halmos G and Schally AV: Somatostatin analog RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostate cancer line in nude mice. Cancer Lett 71: 189-196, 1993.
8. Pinski J, Schally AV, Halmos G and Szepeshazi K: Effects of somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice. Int J Cancer 55: 963-967, 1993.
9. Brevini TA, Bianchi R and Motta M: Direct inhibitory effect of somatostatin on the growth of the human prostatic cancer cell line LNCaP: possible mechanism of action. J Clin Endocrinol Metab 77: 626-631, 1993.
10. Alaiya AA, Oppermann M, Langridge J, Roblick U, Egevad L, Brindstedt S, Hellstrom M, Linder S, Bergman T, Jornvall H and Auer G: Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry. Cell Mol Life Sci 58: 307-311, 2001.
11. Meehan KL, Holland JW and Dawkins HJ: Proteomic analysis of normal and malignant prostate tissue to identify novel proteins lost in cancer. Prostate 50: 54-63, 2002.
12. Ahram M, Best CJ, Flaig MJ, Gillespie JW, Leiva IM, Chuaqui RF, Zhous G, Shu H, Duray PH, Linehan WM, Raffeld M, Ornstein DK, Zhao Y, Petricoin EF and Emmert-Buck MR: Proteomic analysis of human prostate cancer. Mol Carcinog 33: 9-15, 2002.
13. Petricoin EF III, Ornstein DK, Paweletz CP, Ardekani A, Hackett PS, Hitt BA, Velassco A, Trucco C, Wiegand L, Wood K, Simone CB, Levine PJ, Linehan WM, Emmert-Buck MR, Steinberg SM, Kohn EC and Liotta LA: Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst 94: 1576-1578, 2002.
14. Dizeyi N, Konrad L, Bjartell A, Wu H, Gadaleanu V, Hansson J, Helboe L and Abrahamsson PA: Localization and mRNA expression of somatostatin receptor subtypes in human prostatic tissue and prostate cancer cell lines. Urol Oncol 7: 91-98, 2002.
15. Sinisi AA, Bellastella A, Prezioso D, Nicchio MR, Lotti T, Salvatore M and Pasquali D: Different expression patterns of somatostatin receptor subtypes in cultured epithelial cells from human normal prostate and prostate cancer. J Clin Endocrinol Metab 82: 2566-2569, 1997.
16. Reubi JC, Waser B, Schaer JC and Markwalder R: Somatostatin receptors in human prostate and prostate cancer. J Clin Endocrinol Metab 80: 2806-2814, 1995.
17. Franzén B, Linder S, Okuzawa K, Kato H and Auer G: Non-enzymatic extraction of cells from clinical tumour material for analysis of gene expression by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 14: 1045-1053, 1993.
18. Rabilloud T, Vuillard L, Gilly C and Lawrence JJ: Silver staining of proteins in polyacrylamide gels: a general overview. Cell Mol Biol 40: 57-75, 1994.
19. Dysvik B and Jonassen I: J-Express: exploring gene expression data using Java. Bioinformatics 17: 369-370, 2001.
20. Alaiya AA, Franzen B, Moberger B, Silfversward C, Linder S and Auer G: Two-dimensional gel analysis of protein expression in ovarian tumors shows a low degree of intratumoral heterogeneity. Electrophoresis 20(4-5): 1039-1046, 1999.
21. Alaiya AA, Oppermann M, Langridge J, Roblick U et al: Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry. Cell Mol Life Sci 58: 307-311, 2001.
22. Alaiya AA, Roblick UJ, Franzén B, Bruch HP and Auer G: Protein expression profiling in human lung, breast, bladder, renal, colorectal and ovarian cancers. J Chromatogr 787: 207-222, 2003.
23. Brevini-Galdolfi TAL, Cillo F, Favetta LA and Motta M: Somatostatin up-regulates topoisomerase II alpha expression and affects LNCaP cell cycle. Mol Cell Endocrinol 776: 103-110, 2001.
24. Zapata PD, Ropero RM, Valencia AM. Buscail L et al: Autocrine regulation of human prostate carcinoma cell proliferation by somatostatin through the modulation of the SH2 domain containing protein tyrosine phosphatase (SHP)-1. J Clin Endocrinol Metabol 87: 915-926, 2002.
25. Petricoin EF, Ornstein DK, Paweletz CP, Ardekani A et al: Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst 94: 1576-1578, 2002.